In fact, the number of CD8+ cells reflects the activation of antitumor response that depends on the cascade of events within tumor immune cycle including tumor antigens recognition, CD8+ cells differentiation with further recruitment of CD8+ T-cells into the tumor site, and tumor cells elimination (Bellone and Calcinotto, 2013; Maimela et al., 2019). Here, CD8A is linked to neoplasm.